IRLAB names Janne Backman board chair, replacing Carola Lemne

Bitget2026/09/24 15:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

IRLAB Therapeutics named Jan-Fredrik “Janne” Backman chairman, succeeding Carola Lemne, who stepped down in September.
Backman was elected vice chairman at the 2026 annual general meeting.
He previously held strategy, marketing, and R&D program leadership roles at The Medicines Company.
Backman also held commercial positions at Merck Serono, AstraZeneca.
He has served as CEO of J.F.B Consulting AB, J.F.B Invest since 2016.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRLAB Therapeutics AB published the original content used to generate this news brief on September 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

IRLAB names Janne Backman board chair, replacing Carola Lemne

You may also like

Crypto prices